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Abstract
Background: There is consistent evidence showing an inter-
play between psychological processes and immune func-
tion in health and disease processes. Objectives: The present 
systematic review and meta-analysis aims to provide a con-
cise overview of the effectiveness of stress-reducing psycho-
logical interventions on the activation of immune responses 
in both healthy subjects and patients. Methods: Included are 
3 types of challenges: in vivo, in vitro, and psychophysiolog-
ical. Such challenges are designed to mimic naturally occur-
ring immune-related threats. Results: A systematic literature 
search was conducted using PubMed, EMBASE, and PsychIn-
fo, resulting in 75 eligible studies. The risk of bias was as-
sessed with the Cochrane risk-of-bias tool. Across all studies, 
a small-to-medium effect size was found for the effects of 
psychological interventions on optimization of the immune 
function (g = 0.33; 95% CI 0.22–0.43). While the largest ef-
fects were found for in vivo immune-related challenges (g = 
0.61; 95% CI 0.34–0.88; especially on studies that incorpo-
rated skin tests and wound healing), studies incorporating 
psychophysiological challenges and in vitro immune-relat-
ed stimulations similarly suggest more optimal immune re-
sponses among those receiving stress-reducing interven-
tions (g = 0.28; 95% CI 0.15–0.42). Conclusion: These find-
ings showed substantial heterogeneity depending on the 
type of challenge, the study populations, and the interven-
tion types. These data demonstrate support for the effective-
ness of stress-reducing psychological interventions in im-
proving immunity in studies that tested immune function by 
means of incorporating an in vivo, in vitro, or psychophysi-
ological challenge. Future research should more consistent-
ly incorporate challenges into the study design to gather 
more insights in the mechanisms underlying the optimized 
immune function following a psychological intervention. 
This is also relevant for clinical practice, as psychological in-
terventions can possibly supplement, or at least partially 
replace, current drug treatments in various somatic condi-
tions to reduce side effects. © 2019 The Author(s)
Published by S. Karger AG, Basel
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Introduction
Psychosocial features can influence clinical outcomes 
[1–3]. More specifically, stressful events can influence the 
functioning of the immune system [4–6]. Several system-
atic reviews and meta-analyses have overall shown that 
particularly chronic stress suppresses protective immune 
responses and promotes pathological immune responses, 
including inflammatory responses [7–12]. Moreover, 
stress-related disorders, including anxiety and depression, 
also turned out to be associated with affective-related def-
icits through immune alterations [13]. These immune al-
terations can be expressed as slower wound healing [8, 9], 
impaired responses to vaccines [7], and progression of in-
fectious and immune-mediated diseases [7, 14, 15].
Various psychological interventions, including cogni-
tive behavioral therapy [16], mindfulness [17–21], and re-
laxation [17], have been found to effectively reduce stress. 
Therefore, it has been argued that such stress-reducing 
interventions may help to counteract the adverse effects of 
stress on immune functioning. A previous meta-analysis, 
however, found little support for an immune-optimizing 
potential of psychological interventions [22]. Some sup-
porting evidence was provided by studies using condi-
tioning and hypnosis interventions, although the results 
were heterogeneous. Due to substantial variation in im-
mune outcomes, the generalizability was uncertain [22]. 
More specifically, the immune outcomes in these studies 
varied from counting white blood cell subsets to evaluat-
ing cell function by activating the immune system by ei-
ther in vitro (i.e., exposing isolated white blood cells to an 
immune-activating stimulus) or in vivo (i.e., stimulating 
an immune response in the intact person; e.g., vaccina-
tion) methods. Each of these methods provides a different 
window and type of information on the functioning of the 
immune system. Counting cells in a resting state provides 
information on the number of immune cells in the circu-
lation. However, the circulation represents only a small 
and selective proportion of the total cell population, it is 
highly dynamic within individuals, and the normal range 
of adequate cell numbers is rather broad. Therefore, in 
somatically healthy participants cell counts are of uncer-
tain clinical significance. On the other hand, the response 
of the immune system to activating stimuli is considered 
a more representative estimate of a person’s ability to 
mount an adequate immune response in the face of a nat-
ural challenge and may be considered a more biologically 
valid marker of immunocompetence [23].
In vitro activations include natural killer cell activity 
(NKCA), a stimulated lymphocyte proliferation response 
(LPR), and stimulated proinflammatory and anti-inflam-
matory cytokine production (i.e., chemical challenges), 
whereas in vivo stimulations include hypersensitivity re-
sponses to skin tests, the time of healing of a biopsy wound, 
or the extent to which a vaccine produces antibodies (i.e., 
physical challenges). In addition to the above-mentioned 
in vitro and in vivo activations of the immune system, psy-
chosocial stress can also challenge the immune system [4, 
5, 24, 25]. Therefore, a number of studies have evoked 
psychosocial stress in their participants by exposing them 
to psychophysiological challenges, i.e., challenges that 
have the potential to evoke a psychophysiological stress 
response, including exposure to a psychosocial stress task, 
to obtain additional information on how stress-reducing 
psychological interventions may optimize the extent to 
which the immune system responds to these challenges 
[26]. A recent systematic review provided support for the 
effectiveness of psychological interventions in optimiza-
tion of wound healing [27]. There is, however, no recent 
examination of the effectiveness of stress-reducing inter-
ventions on a broader range of immune challenges, also 
taking psychophysiological challenges into account. 
In the last few decades, studies have evaluated how the 
immune system responds to chemical, physical, and psy-
chophysiological challenges after undergoing a stress-re-
ducing psychological intervention. Previous systematic re-
views and meta-analyses, including the systematic review 
and meta-analysis of Miller and Cohen [22] in the previous 
century, have already summarized the effectiveness of psy-
chological interventions on immune function [20, 27]. 
This study incorporated various outcome measures that 
were assessed during resting states or after a challenge. 
However, the focus of this previous study was not on chal-
lenges per se and it did not assess the immune response 
after psychophysiological challenges. It can be presumed 
that exposing participants to different kind of challenges, 
i.e., chemical, physical, or psychophysiological, provides 
more insights in the actual responsiveness of the immune 
system to a natural challenge compared to assessing resting 
state outcomes. Therefore, the aim of the current system-
atic review and meta-analysis is to summarize the effective-
ness of stress-reducing psychological interventions direct-
ed at optimizing immune function, focusing on studies 
incorporating various in vivo or in vitro immune-related 
and/or psychophysiological stimulations/challenges into 
the study design. We expected that after a stress-reducing 
psychological intervention participants would show a 
more optimized immune response to challenges as com-
pared to participants who did not receive a stress-reducing 
psychological intervention. More specifically, after the 
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stress-reducing psychological intervention we expected 
a higher NKCA, higher anti-inflammatory cytokine re-
sponses, lower proinflammatory cytokine responses, high-
er LPR, higher antibody responses, and higher delayed-
type hypersensitivity responses, as well as faster wound 
healing. We analyzed the pooled effects of the 3 types of 
challenges together as well as separately. 
Methods
This systematic review and meta-analysis was performed 
according to PRISMA criteria [28] and it was registered in 
PROSPERO (registration No. CRD42017055722).
Inclusion and Exclusion Criteria
Studies were included when they met the following inclusion 
criteria according to PICO criteria [29]: (P) incorporation of hu-
man participants (patients or healthy participants); (I) a stress- 
reducing psychological intervention (which was defined as having 
cognitive behavior change techniques [30] as the main component, 
i.e., duration of more than 50% of the intervention time, such as 
psychotherapy, mindfulness, or relaxation) – interventions that 
combined psychological intervention components with physical 
intervention components were only included when the focus of the 
intervention was on the psychological components, i.e., more than 
50% of the intervention; (C) incorporation of at least 1 control 
group without a stress-reducing psychological intervention; and 
(O) inclusion of immune outcome measures assessed in blood or 
saliva (e.g., quantification of cytokines and lymphocytes) as well as 
incorporation of immune-related and/or psychophysiological 
challenges into the study design which were assessed after the start 
of the stress-reducing psychological intervention. Articles were ex-
cluded when they assessed immunological functioning not by ob-
jective measurements or parameters, but when they were, for ex-
ample, solely based on self-reports (e.g., self-reported infection), 
when they were based on case studies, or when they had insufficient 
methodological or statistical details about the immune or psycho-
physiological challenges or results (e.g., conference abstracts). 
Literature Search Strategy
A systematic search was conducted using the databases PubMed, 
EMBASE, and PsychInfo until January 26, 2017. The search terms 
included Medical Subject Headings (MeSH) and words from title/
abstract (tiab) as qualifiers, classified in 3 categories: stress-reduc-
ing psychological interventions, immune function, and immune-
related as well as psychophysiological challenges (for the search 
strategy per database, see online suppl. Table 1; for all online suppl. 
material, see www.karger.com/doi/10.1159/000501645). All re-
trieved references were loaded into Endnote and 2 independent 
reviewers (L.S. and P.C.) screened the titles, abstracts, and subse-
quently full texts when appropriate regarding study eligibility and 
relevance. The reference lists of the included studies were addition-
ally searched for potential eligible studies.
Data Extraction
A data extraction form was used to extract relevant data from 
the eligible studies. The extracted information for each study in-
cluded: study population (e.g., healthy participants or patients); 
participant demographics; details of the intervention and control 
conditions; study methodology; incorporated chemical, physical, 
and/or psychophysiological challenges; immune outcome param-
eters; relevant outcome data; statistical analyses; and relevant in-
formation concerning the methodological quality assessment. The 
information was extracted by the 2 reviewers (L.S. and P.I.C.) in-
dependently. Discrepancies were identified and resolved through 
discussion by involving one or more additional reviewer(s) (D.S.V., 
J.A.B., and A.W.M.E.).
Methodological Quality Assessment in the Included Studies
Two reviewers (L.S. and P.I.C.) furthermore independently as-
sessed the risk of bias (RoB) of the included studies using the 
Cochrane RoB tool [31]. The biases that were assessed included: 
selection bias (process of randomization and concealment of al-
location), performance bias (blinding of participants and research 
personnel), detection bias (blinding of outcome assessment), re-
porting bias (handling of missing data), and attrition bias (descrip-
tion of reasons for withdrawal in all conditions). Biases were clas-
sified as being low, high, or unclear. Disagreements between the 
review authors regarding the RoB in particular studies were re-
solved by discussion, with involvement of a third review author 
(D.S.V.) if necessary. 
Data Analyses
Data were analyzed using Comprehensive Meta-Analysis soft-
ware version 3.3.070 (Biostat, Englewood, CO, USA). Hedges’ g 
was the effect size metric that was applied in the descriptive statis-
tics of this study. The effect size was calculated by subtracting the 
pre- from the post-immune outcome parameters in the control 
group and subsequently subtracting this difference score from the 
difference score in the intervention group, divided by the pooled 
SD and weighted across the number of subjects in each group. Ef-
fect sizes of 0.2 can be considered small, whereas 0.5 and 0.8 can 
be considered medium and large, respectively [32]. For the includ-
ed studies performing within-subjects comparisons, the pre-post 
correlation coefficient could not be derived and therefore a corre-
lation coefficient of r = 0.05 was imputed. In case a study contain-
ing multiple conditions with eligible psychological interventions, 
these groups were combined into a single pairwise comparison, 
according to the recommendations of the Cochrane handbook 
[31]. The pooled effects were analyzed using a random-effects 
model. Heterogeneity was assessed by evaluating the I2 statistic and 
by visual inspection of the forest plot. Values of I2 = 25, 50, and 
75% can be interpreted as low, moderate, and high heterogeneity, 
respectively. In cases in which the results of a study were based on 
postintervention scores only (e.g., in the case of wound healing 
studies), the effect size was based on the postintervention scores. 
When the descriptive statistics were not available authors were re-
quested to provide those data, and when the data were not pro-
vided alternative methods were used to calculate the effect size 
(e.g., using reported statistics, reported mean change scores, etc.). 
When studies reported that the results were not significant, with-
out further specification of the outcomes, effect sizes were com-
puted assuming no differences between the groups (r = 0.00). Be-
cause this is a rather conservative strategy that had to be applied to 
a substantial proportion of the data (i.e., imputation was used in 
23.8% of the cases), meta-analyses were performed with and with-
out those studies in order to evaluate the potential bias of this 
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method. All immune outcomes were scaled in the direction of pos-
itive Hedges’ g representing an optimized immune function. More 
specifically, a higher NKCA, higher anti-inflammatory cytokine 
responses, lower proinflammatory cytokine responses, higher 
LPR, higher antibody responses, and higher delayed-type hyper-
sensitivity responses, as well as faster wound healing, were inter-
preted as optimized immune outcomes.
The pooled effects of all 3 different types of challenges (i.e., in 
vitro immune-related stimulations, in vivo immune-related chal-
lenges, and psychophysiological challenges) were analyzed together 
and separately. The in vitro immune-related stimulations were sub-
sequently subcategorized into NKCA, stimulated LPR, and stimu-
lated cytokine production. In vivo immune-related challenges were 
subdivided into wound healing, vaccine responses, and immediate 
as well as delayed-type hypersensitivity responses after skin tests. In 
vivo psychophysiological challenges were further subdivided into 
acute and more protracted stress challenges, separately for plasma 
numbers of lymphocytes (i.e., enumeration of CD4, CD8, and CD56 
numbers) and cytokines (i.e., quantification of IL-1β, IL-6, IL-8, and 
TNF-α). When the outcomes of in vitro stimulations were assessed 
on multiple concentrations of the stimulus (e.g., multiple effector-
to-target ratios to evaluate NKCA or various dilutions to evaluate 
LPR), the effect size was derived from the concentration that most 
optimally differentiated conditions (i.e., the stimulus concentrations 
that showed the largest differences). Planned subset analyses evalu-
ated the effects of different types of challenges within a specific cat-
egory. 
Data of at least 3 studies had to be available in order to conduct 
a meta-analysis. Sensitivity analyses were performed concerning 
the reliability of the results in that it was investigated whether the 
results would remain comparable when taking RoB and publica-
tion bias into account. In order to assess the stability of the overall 
effect size, it was investigated whether the effects were similar 
when studies with a substantial RoB (i.e., studies containing at least 
1 classification of high RoB) were excluded from the analyses. In 
addition, publication bias was assessed by inspection of the funnel 
plot and applying the trim-and-fill method of Duval and Tweedie 
[33]. 
Results
Search Results
Online suppl. Figure 1 shows the flow chart of the sys-
tematic search and study selection. A total of 19,780 studies 
(including duplicates) were found by searching PubMed, 
EMBASE, and PsychInfo. After removing duplicates and 
screening the studies on title and abstract, 138 articles were 
examined in full text by the 2 independent reviewers. Of 
those, 65 articles fulfilled the inclusion criteria. Screening 
of the reference lists of the included articles yielded 9 ad-
ditional eligible studies, which were not identified in the 
primary search as most of these studies did not specify im-
mune outcome measures in the title and/or abstract. In 
total, 75 studies reported in 74 articles were included.
Study Characteristics
A total of 4,141 participants took part in the 75 studies. 
Detailed information concerning the study characteristics 
and incorporated psychological interventions are de-
scribed in online suppl. Table 2. The total individual study 
sample size varied between 12 [34] and 252 subjects [35] 
(mean = 57, SD = 48). In 29 studies (38.7%), healthy vol-
unteers were included as the study population [34, 36–62]. 
Other samples included patients or vulnerable adults, e.g., 
patients with various types of cancer [63–82], patients with 
HIV infection [35, 83–87], patients with rheumatoid ar-
thritis [26, 88–90], older adults [91–94], patients with asth-
ma/allergies [95–97], widows/women who had lost a close 
relative to cancer [98, 99], patients with ulcerative colitis 
[100, 101], women with depression after bypass surgery 
[102], patients with late-life insomnia [103], women suf-
fering from infertility [104], veterans [105], and patients 
who had undergone surgery [106]. The mean age of the 
participants varied between 18.5 and 78.8 years. Details on 
age were not provided in 7 studies (9.3%). Twenty-four 
studies (32.0%) only included female participants, whereas 
9 studies (12.0%) only included male participants. In 36 
studies (48.0%), both males and females were included. 
Details on gender were not reported in 6 studies (8.0%).
RoB Assessment
Online suppl. Figure 2 presents the RoB graph and on-
line suppl. Figure 3 the RoB summary. Of the 75 studies, 
68 (90.7%) did not provide sufficient details on the meth-
ods used to randomize participants and 71 articles (94.7%) 
did not sufficiently specify the methods of allocation con-
cealment (unclear RoB). RoB on performance was low for 
2 articles (2.7%) due to adequate blinding procedures. In 
9 articles (12.0%), participants and/or personnel were 
aware of the group allocation, which could have led to 
performance bias (high RoB). For 26 articles (34.7%), the 
RoB concerning a lack of blinding of participants and 
personnel was low. In 35 articles (46.7%), the drop-out 
rates and reasons for drop-out were sufficiently described 
and unrelated to the study outcomes, which resulted in a 
low RoB evaluation regarding incomplete outcome data. 
No study protocol was available for 73 articles (96.1%), 
resulting in an unclear RoB regarding selective reporting. 
Type of Stress-Reducing Psychological Interventions
In total, 82 stress-reducing psychological interven-
tions were evaluated in the 75 studies. Most interven-
tions (28 interventions; 34.1%) were based on relaxation 
or stress management. Multicomponent cognitive-be-
havioral interventions, including psycho-education and 
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various cognitive and behavioral techniques, were also 
common and assessed in 18 cases (22.0%). Other inter-
ventions were based on manualized mindfulness and/or 
meditation (13 interventions; 15.9%), hypnosis (12 in-
terventions; 14.6%), emotional disclosure (7 interven-
tions; 8.5%), and counseling (4 interventions; 4.9%). The 
interventions varied in their total duration from a single 
session to multiple sessions over a period of 12 months.
Regarding the guidance of the interventions, all inter-
ventions included face-to-face or telephone appoint-
ments, except for 2 interventions that relied on self-prac-
tice. Of the guided interventions, 48 (58.5%) also encour-
aged self-practice.
Overall Immune Effects
Detailed information concerning the immune-related 
challenges and outcomes for each study is presented in 
online suppl. Table 3.
When performing an overall random-effects meta-
analysis on the data, i.e., irrespectively of the incorporat-
ed challenge, an overall small effect size was found (k = 
84, g = 0.33; 95% CI 0.22–0.43), with moderate heteroge-
neity across the studies (I2 = 59.41%). When excluding 
the studies that were set at r = 0.00, a slightly higher over-
all small effect size was found (k = 64, g = 0.43; 95% CI 
0.30–0.55, I2 = 67.69%).
Exploratory Analyses for Participants with and 
without Somatic Conditions
For studies that incorporated patients with somatic 
conditions, a small overall effect size was found (k = 40, 
g = 0.34; 95% CI 0.17–0.52), with moderate heterogeneity 
across the studies (I2 = 71.94%).
For studies that incorporated participants without so-
matic conditions, also a small overall effect size was found 
(k = 44, g = 0.31; 95% CI 0.20–0.43), with low heterogene-
ity across the studies (I2 = 34.10%).
In vitro Immune-Related Stimulations
Of the 75 studies, 52 (68.4%) incorporated at least 1 in 
vitro immune stimulation test, including NKCA (32 stud-
ies), LPR (28 studies), cytokine production (10 studies), 
and monocyte chemotaxis (1 study).
Online suppl. Figure 4 presents the forest plot on the 
random-effects meta-analysis for in vitro immune-related 
stimulations. Overall, a small effect size was found (k = 52, 
g = 0.28; 95% CI 0.15–0.42), with moderate heterogeneity 
across the studies (I2 = 61.43%). After excluding the stud-
ies that were set at r = 0.00, a small effect size was found 
(k = 39, g = 0.39; 95% CI 0.22–0.56, I2 = 70.75%). When 
looking at specific subgroups of in vitro immune stimula-
tion tests, we found a small effect size for NKCA (k = 31, 
g = 0.21; 95% CI 0.06–0.35, I2 = 40.22%), LPR (k = 28, g = 
0.35; 95% CI 0.13–0.57, I2 = 73.07%), and cytokine pro-
duction (k = 9, g = 0.32; 95% CI 0.14–0.51, I2 < 0.01%).
Exploratory Analyses for Participants with and 
without Somatic Conditions
For studies that incorporated patients with somatic 
conditions, a small effect size was found (k = 33, g = 0.28; 
95% CI 0.10–0.46), with moderate heterogeneity across 
the studies (I2 = 69.54%).
For studies that incorporated participants without so-
matic conditions, also a small effect size was found (k = 
19, g = 0.28; 95% CI 0.08–0.48), with low heterogeneity 
across the studies (I2 = 33.76%).
In vivo Immune-Related Challenges
In vivo immune-related challenges, including skin 
testing (8 studies), vaccination (5 studies), and wound 
healing (4 studies), were incorporated into the study de-
signs of 17 studies (22.4%). 
Online suppl. Figure 5 presents the results of the ran-
dom-effects meta-analysis on the pooled effects of in vivo 
immune-related challenges. A medium effect size was 
found (k = 17, g = 0.61; 95% CI 0.34–0.88), with high het-
erogeneity across the studies (I2 = 74.59%). After exclud-
ing the studies that were set at r = 0.00, a similar medium 
effect size was found (k = 15, g = 0.64; 95% CI 0.35–0.92, 
I2 = 76.73%). When looking at specific subgroups within 
the in vivo immune-related challenges, a large effect size 
was found for studies using skin tests (k = 8, g = 0.80; 95% 
CI 0.30–1.30, I2 = 80.72%). Furthermore, a small effect 
size was found for vaccine studies (k = 5, g = 0.37; 95% CI 
–0.17 to 0.90, I2 = 77.69), and a medium effect size was 
found for wound healing studies (k = 4, g = 0.75; 95% CI 
0.45–1.05, I2 < 0.01%). 
Exploratory Analyses for Participants with and 
without Somatic Conditions
For studies that incorporated patients with somatic 
conditions, a high effect size was found (k = 4, g = 1.5; 95% 
CI 0.4–2.7), with high heterogeneity across the studies 
(I2 = 86.973%).
For studies that incorporated participants without so-
matic conditions, a medium effect size was found (k = 17, 
g = 0.61; 95% CI 0.34–0.88), with moderate heterogeneity 
across the studies (I2 = 74.59%).
Most studies were based on skin testing. Of the 4 stud-
ies that included patients with somatic conditions, 3 stud-
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ies included allergic patients who were exposed to skin 
tests, and yielded high effect sizes (k = 3, g = 2.02; 95% CI 
–0.03–4.06). Five studies were found that included par-
ticipants without somatic conditions. When these study 
findings were compared to the patients with somatic con-
ditions, small effect sizes were found (k = 5, g = 0.28; 95% 
CI 0.05–0.51).
Psychophysiological Challenges
In 16 studies (19.7%), a psychophysiological challenge 
was incorporated; acute challenges included a speech 
task, exams, a cold pressor test, and a treadmill exercise 
test (10 studies), and challenges of a more protracted 
character, including academic stress and HIV serostatus 
notification (6 studies).
In online suppl. Figure 6, the results of the random-
effects meta-analysis on the pooled effects of psychophys-
iological challenges is shown. One study was not included 
in the meta-analysis as the outcomes of that study were 
not based on plasma measurements, T-cell enumeration, 
or cytokine quantification. Overall, no effect was found 
(k = 15, g = 0.18; 95% CI 0.01–0.35, I2 < 0.01), whereas a 
small effect size was found when excluding the studies 
that were set at r = 0.00 (k = 10, g = 0.28; 95% CI 0.07–0.49, 
I2 < 0.01). When assessing studies that incorporated enu-
meration of lymphocyte subsets after a psychophysiolog-
ical challenge (i.e., CD4, CD8, and CD56), a small effect 
size was found for studies incorporating a more protract-
ed stress challenge (k = 4, g = 0.33; 95% CI = –0.06 to 0.72, 
I2 = 1.68%). For acute stress challenges, there were not 
enough studies available that had incorporated those 
markers in order to evaluate the effects after an acute 
stress challenge (k = 2). For studies that incorporated 
plasma cytokine measurements (i.e., IL-1β, IL-6, IL-8, 
and TNF-α) after a psychophysiological challenge, a small 
effect size was described in studies incorporating an acute 
challenge (k = 4, g = 0.22; 95% CI –0.04 to 0.49, I2 < 0.01%), 
whereas no studies incorporated those markers to evalu-
ate the effects after a more protracted stress challenge.
Exploratory Analyses for Participants with and 
without Somatic Conditions
 For studies that incorporated patients with somatic 
conditions, no effect was found (k = 3, g = 0.11; 95% CI 
–0.21 to 0.42), with low heterogeneity across the studies 
(I2 < 0.01%). 
For studies that incorporated participants without so-
matic conditions, also no effect was found (k = 12, g = 
0.22; 95% CI 0.01–0.42), with low heterogeneity across 
the studies (I2 <  0.01%).
Sensitivity Analyses
RoB within Studies
When studies with a presumed high RoB were exclud-
ed from the analyses, 23 of 84 outcomes were excluded. 
However, the overall effect size was not substantially al-
tered (k = 61, g = 0.34; 95% CI 0.20–0.48).
Publication Bias
The funnel plot is displayed in online suppl. Figure 7 
and suggests the presence of publication bias. The trim-
and-fill method indicates that 12 studies were expected to 
be missing with below-average effects, as indicated by the 
black dots. When imputing those studies, the effect size 
decreased to g = 0.21 (95% CI 0.09–0.32).
Discussion
Over the last few decades, studies have evaluated the 
effectiveness of stress-reducing psychological interven-
tions on immune function by incorporating chemical, 
physical, and psychophysiological challenges into the 
study design. These challenges are thought to present a 
biologically more valid reflection on the effectiveness of 
stress-reducing psychological interventions in optimiza-
tion of the immune function as compared to unstimu-
lated quantitative immune outcomes [23, 107, 108]. The 
present systematic review and meta-analysis summarized 
immune-related outcomes after a chemical, physical, or 
psychophysiological challenge following a stress-reduc-
ing psychological intervention in both healthy subjects 
and patients. 
Overall, the findings demonstrated a small (heteroge-
neous) positive effect size for optimization of the immune 
function. As a conservative method was applied to handle 
studies that reported no significant results without fur-
ther specifying the actual group differences, the overall 
effect size possibly represents a slightly underestimated 
effect size. While the largest effects were found for in vivo 
immune-related challenges (especially in studies that in-
corporated skin tests and wound healing), studies incor-
porating psychophysiological challenges and in vitro 
immune-related stimulations similarly suggest more 
optimal immune responses among those receiving 
stress-reducing interventions.
When focusing on in vitro immune-related stimula-
tions, small effect sizes were found. Studies were highly 
diverse regarding the source of material and technical de-
tails of the stimulation. For example, studies varied in the 
target of stimulation (e.g., stimulation of T cells and NK 
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cells), the types of outcomes (e.g., proliferation, cytokine 
production, and killing monocytes) and the types of con-
centrations and the duration of stimuli. Likewise, a subset 
of studies stimulated whole blood, thereby performing 
tests in a biologically normal blood-plasma context, 
whereas others stimulated peripheral blood mononuclear 
cells, whereby tests are performed in artificial buffer solu-
tions. Therefore, whole blood stimulations comprise a 
rather diverse range of cell populations (e.g., neutrophils, 
eosinophils, etc.), whereas the cell populations in periph-
eral blood mononuclear cells are more well-defined, re-
sulting in different environments of stimulation. In addi-
tion, important details such as the concentrations used or 
which type of immune cells were stimulated, were often 
lacking from the Methods section, while such aspects may 
substantially influence the results. Future studies are 
therefore encouraged to report more carefully on the 
methodological details. This could, for example, be ac-
quired by applying a standard format for reporting the 
methodology, such as the Minimum Information About 
a Microarray Experiment (MIAME) guidelines [109] or 
the Minimal Information About T cell Assays (MIATA) 
standard [110]. In addition, since in vitro stimulations are 
applied outside the body, those challenges may comprise 
a less biologically relevant valid representation of real-life 
immune threats as compared to in vivo challenges, al-
though in vitro immune-related stimulations are easier to 
implement into the study design.
When focusing on in vivo immune-related challenges, 
studies on skin tests and wound healing found largest ef-
fect sizes and were mostly based on evaluating wound size 
alteration instead of quantitative immune outcome mea-
sures. These outcome parameters contain a rather unidi-
rectional and straightforward representation of immune 
function (i.e., faster wound healing represents a more op-
timal immune response). Thus, of all of the immune-re-
lated challenges examined, the most convincing evidence 
was found for stress-reducing psychological interven-
tions optimizing the immune performance in cases of 
wound healing (medium effect size) and skin-based tests 
(high effect size). Even though these immune-related 
challenges probably represent a general stimulation of the 
immune performance, this could imply that stress-reduc-
ing interventions could be particularly clinically relevant 
for patients with immune-related skin conditions, such as 
patients recovering from inflammation-sensitive surgical 
wounds. Contrary to these findings, only a small effect 
size was found for vaccines. Due to the small number of 
studies that incorporated a vaccine (5 studies), and varia-
tion in the type of incorporated vaccines and the included 
time points (influenza vaccines, but also 1 study with a 
hepatitis B vaccine incorporating various measurement 
points), the present meta-analysis could not provide a 
conclusive view on this subcategory of in vivo immune-
related challenges. As few studies incorporated a vaccine, 
future research would be helpful to further elucidate the 
effects of psychological interventions on in vivo immune-
related challenges, particularly in the area of vaccination 
and related immune outcomes. 
For studies incorporating psychophysiological chal-
lenges, small effect sizes on immune measures were found 
when incorporating acute challenges (e.g., exam stress), 
and small effect sizes were found when incorporating 
chronic stressors (e.g., academic stress). Although the 
data did not seem to display a high statistical heterogene-
ity, the incorporated challenges and immune outcome 
parameters were highly diverse across studies. More spe-
cifically, studies included acute challenges such as exams, 
speech tasks (some accompanied with or without a men-
tal arithmetic task), a treadmill exercise test, and a cold 
pressor task, as well as more protracted stress challenges 
such as serostatus notification for individuals undergoing 
HIV testing and academic stress experienced by students 
during an examination period. Since the findings of the 
present study were based on a small number of studies 
with mostly limited ecological validity of the stressors, 
i.e., only some included challenges represented chronic 
stress as experienced by people in daily life, future work 
should focus on incorporating stressors with a high exter-
nal validity (e.g., social-evaluative stressors for socially 
anxious subjects or more daily-life chronic stress such as 
rumination) in order to evaluate the effects of psycho-
logical interventions on immune function [5]. 
Most the studies that incorporated psychophysiologi-
cal challenges involved healthy participants (14 out of 17 
studies). As healthy participants are supposed to have a 
well-functioning immune system, they are expected to 
show responses within the normal range to standard im-
mune system challenges also in absence of a stress-reduc-
ing psychological intervention [5]. The challenging situ-
ation to which these healthy participants are exposed, 
therefore, must be powerful enough to detect any rele-
vant alterations in immune function in response to a psy-
chological intervention. It is possible that combination 
of a psychophysiological challenge with an in vivo im-
mune-related challenge can boost the effects of the sepa-
rate challenges and possibly provide healthy participants 
with a more robust immune system challenge. Only 1 
study in the present systematic review and meta-analysis 
combined an in vivo immune-related challenge, i.e., suc-
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tion blisters on the volar forearm, with a psychophysio-
logical challenge, i.e., a Trier social stress test, to evaluate 
the effects of a stress-reducing psychological interven-
tion [55]. In that study, participants who received a 
stress-reducing mindfulness intervention showed a low-
er post-stress (i.e., after the Trier social stress test) in-
flammatory response to the in vivo immune-related and 
psychophysiological challenges compared to a control 
group that received a control health enhancement pro-
gram. The incorporation of both an in vivo immune-re-
lated challenge and a psychophysiological challenge pro-
vides a more elaborate view of the underlying processes 
of immune function after a psychological intervention, 
i.e., evaluating immune function after activation of the 
immune system through different challenges that can 
boost each other’s effectiveness. Future studies may con-
sider incorporating multiple challenges into their design 
when examining immune function in healthy partici-
pants in order to hypothetically provide them with a 
rather robust challenge [111]. 
Regarding the effective components of stress-reducing 
psychological interventions, no strong conclusions can 
be drawn at this point due to the substantial heterogeneity 
in the incorporated intervention elements across studies, 
including the duration and number of sessions, the inter-
vention target, and ways of guidance (e.g., self-practice, 
structured guided sessions, etc.). An exploratory evalua-
tion of the data, however, showed that multiple studies 
explored the role of self-practice during the intervention 
(e.g., completing homework assignments) for immune 
outcomes [36, 38, 41, 46, 47, 52, 55, 59, 68, 75, 78, 106]. 
Most of those studies found a positive association be-
tween the frequency of self-practice and optimized im-
mune outcomes [36, 46, 47, 52, 55, 68, 78]. Although we 
could not formally test this observation in our meta-anal-
ysis due to substantial heterogeneity in study designs 
(e.g., selection of immune outcomes and differences in 
level of details concerning the specification of self-prac-
tice frequency), these findings possibly point to the im-
portance of engaging participants with components of 
the psychological intervention. However, it is important 
to note that the studies included in the present system-
atic review and meta-analysis varied widely in the way 
in which engagement and the actual effectiveness of 
the stress-reducing psychological intervention was eval-
uated. 
The clinical relevance of the present findings is that we 
demonstrated that changes in immune parameters are 
found following the incorporation of a challenge into the 
design of the psychological intervention. Therefore, psy-
chological interventions have the potential to alter the 
immune function which can be relevant to different dis-
orders where immune function is affected. The current 
findings are in line with previous findings regarding the 
clinical relevance of altered immune function findings af-
ter psychological interventions. More specifically, a study 
of Antoni et al. [66] in women with breast cancer showed 
altered cytokine responses after a psychological interven-
tion in response to an in vitro immune-related challenge, 
suggesting that psychological interventions could opti-
mize the host resistance to cancer. In another study of 
Antoni et al. [36], they found that a psychological inter-
vention could buffer stress responses after a psychophys-
iological challenge (i.e., serostatus notification) in pa-
tients with HIV. Although the effect sizes in the context 
of in vitro immune-related challenges were small in the 
present meta-analysis and no significant effects were 
found for psychophysiological challenges, in vivo im-
mune-related outcomes showed medium effect sizes. 
Therefore, the effects of psychological interventions 
might be less prominent at a cellular level, but it seems to 
be mainly expressed in response to chemical challenges. 
Particularly for the in vivo challenges, we found explor-
atory that the effectiveness of a psychological interven-
tion in allergic participants by exposing them to skin tests 
yielded highest effect sizes [91–93]. These findings are 
presumably due to the fact that skin tests provide a rather 
sensitive immune function parameter in allergic patients. 
As the results of these studies provide insights not only in 
that a psychological intervention can alter immune func-
tion but also specifically in how a psychological interven-
tion can result in less symptoms for an allergic condition, 
they aid in the understanding of the extent to which a 
psychological intervention can possibly support regular 
treatments for a specific condition, in this case allergic 
reactions. For this reason, it would be interesting to con-
sider psychological interventions as add-on treatments to 
conventional medicine in allergic patients to buffer anti-
allergic responses. As this finding was based on explor-
atory analyses, future studies should investigate this fur-
ther and preferably focus on incorporating a challenge 
that adequately matches the incorporated study sample. 
We also found a medium effect size for the effectiveness 
of psychological interventions in wound healing studies. 
Therefore, psychological interventions may be an effec-
tive add-on to conventional medicine, for example for 
surgery patients to facilitate recovery after a surgical in-
tervention. To reduce the side effects of conventional 
medicine, it would also be interesting to investigate 
whether those interventions can at least partially replace 
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regularly used treatments in, for example, patients with 
chronic ulcers. 
The present meta-analytic review provides a rather 
comprehensive view on the effectiveness of psychological 
interventions on optimization of immune function by 
only incorporating studies that included a challenge into 
the study design, as more insights are gathered in the ac-
tual responsiveness of the immune system in response to 
a challenge. This not only contributes to the scientific lit-
erature but is also interesting for clinical practice. Fur-
thermore, the present meta-analytic review extends the 
existing knowledge on the effectiveness of mind-body 
therapies in optimization of immune outcomes. More 
specifically, a descriptive review on the effectiveness of 
mind-body therapies in optimization of inflammatory 
markers already showed promising results [109]. How-
ever, mind-body therapies are based on multiple physical 
and psychological components. By including stress-re-
ducing psychological interventions with cognitive behav-
ior change techniques as the main component in the pres-
ent meta-analytic review, more insights are gathered in 
the potential effectiveness of psychological intervention 
components in optimization of immune function. As the 
present meta-analytic review overall found a small posi-
tive effect of psychological interventions in optimization 
of immune function, with the highest effect sizes for stud-
ies incorporating in vivo immune-related challenges, fu-
ture research should investigate whether psychological 
interventions can supplement, or possibly partially re-
place, current drug treatments in various somatic condi-
tions to reduce side effects.
Besides the above-mentioned strengths, there are a 
couple of limitations that should be mentioned. First of 
all, due to the heterogeneity of the incorporated patient 
samples, psychological interventions, immune outcome 
parameters, and challenges of the included studies the 
present meta-analytic review could not provide a conclu-
sive view on the effectiveness of psychological interven-
tions on optimizing immune function. Future studies 
should systematically incorporate challenges to evaluate 
the effectiveness of a psychological intervention on im-
mune function and adequately match the incorporated 
challenge(s) and psychological intervention with the in-
cluded study population in order to gather a more homo-
geneous view on this topic. Second, we found additional 
studies based on screening of the reference lists of the in-
cluded studies that were not identified in the primary 
search. Most of these studies did not specify immune out-
come measures in the title and/or abstract. We cannot 
rule out that more studies were omitted in the present 
meta-analytic review due to a lack of sufficient specificity 
on the incorporation of immune outcome parameters in 
the title and/or abstract. It is important for future studies 
to specify immune outcome measures specifically in the 
title and/or abstract to ensure that they can be detected in 
searches. In addition, future systematic reviews and me-
ta-analysis should be aware that some studies can be over-
looked (i.e., in the case of studies that assess immune 
function without immune outcome parameters, as can be 
the case in wound healing studies) when including the 
immune outcome parameters as a category in their search. 
Therefore, a more general search term may be preferable 
when providing a systematic search on this topic. Third, 
a substantial number of studies did not report on wheth-
er the intervention was actually effective in reducing 
stress, making it hard to take this factor into account in 
our analyses. For the same reason, it was not possible to 
control for confounding factors, including BMI, recent 
illness, female menstruation cycle, and so on. As failures 
to improve immunity can be due to the fact that the stress-
reducing psychological interventions were actually not 
effective in reducing stress, future studies should also 
carefully evaluate to what extent participants were en-
gaged with the stress-reducing psychological interven-
tion and whether these interventions were effective in re-
ducing stress. To optimize the methodological aspects of 
the study design, future studies should take into account 
the recommendations of a recent review [112]. Finally, 
the present findings were based on the assumption that 
higher levels of immune activation were associated with 
a more optimized immune response. However, enhanced 
immune responses are not necessarily beneficial, e.g., in 
the case of inflammatory and autoimmune disorders, 
making it important to take the type of immune response 
into account [113]. In certain cases, optimization is not 
based on larger immune responses but rather on normal-
ization of immune outcomes, making it hard to assess 
optimized immune function as a linear function and to 
compare various types of immune outcome parameters. 
Future studies should therefore take the incorporated im-
mune parameters and the type of response, as well as the 
studied population, into account when evaluating the ef-
fectiveness of a psychological intervention on immune 
function. Note that, as the aim of a stress-reducing psy-
chological intervention is to optimize health outcomes by 
stress reduction, it would be relevant to recruit individu-
als who experience chronic stress with a substantial im-
pact on immune function to evaluate the effectiveness of 
stress-reducing psychological interventions [22]. In addi-
tion, future studies should focus on unraveling the effec-
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tive intervention components in optimization of immune 
responses by evaluating the effectiveness of intervention 
components separately but also in combination with each 
other. 
In conclusion, the present systematic review and meta-
analysis provided evidence for the effects of stress-reduc-
ing interventions in optimization of immune function 
when immune outcomes were evaluated using tests that 
apply challenges to the immune system. While consistent 
evidence came from studies that evaluated immune func-
tion through an in vivo immune-related challenge, spe-
cifically studies incorporating skin tests and studies on 
wound healing, similar but smaller effect sizes were found 
for in vitro immune-related stimulations and immune re-
sponses to psychophysiological challenges. Due to the 
large heterogeneity in study designs, there is a need for 
future research that incorporates immune- and psycho-
physiological challenges, as these have a high external va-
lidity and are suitable for possible clinical applications in 
immune-related diseases. Studies in healthy participants 
have to make sure that the immune challenge is robust 
enough, e.g., by combining separate challenges. Finally, 
future studies should carefully report on the methodolog-
ical details according to standardized guidelines, includ-
ing the actual stress-reducing effectiveness of the psycho-
logical interventions, and appropriate interpretation of 
the immune outcomes. This can result in further insights 
into the immune outcomes that are responsive to change 
as well as a thorough view on the effective intervention 
components to optimize immune responses in the short 
and longer term.
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